At McMillan Research, we take a unique approach to medical research, applying the fundamentals of physiology and pathology to understand disease.

Through detailed research on COVID-19, a theory of autoimmunity to angiotensin-converting enzyme II (“ACE-2”) was formulated in April 2020, and has gradually gained credence.

Dr McMillan has collaborated with experts to publish scientific papers in May 2020, explaining the concept of autoimmunity in COVID-19, and March 2021, proposing a more detailed and comprehensive explanation of the symptoms associated with COVID-19.

The aim of the COVID-19 research project is to advance our understanding of immune dysregulation in COVID-19. This is the primary cause of lung damage which can lead to death. The outcome of the research project has the potential to change the course of the pandemic.